Market research
4880.TSE CellSource Co., Ltd
TSE JPY Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 6B
- P/E ratio
- 89.33
- Analyst target
- 880
- Dividend yield
- 1.5%
- Beta
- -0.09
Profile
Company facts
- Exchange
- TSE
- Currency
- JPY
- Sector
- Healthcare
- Industry
- Biotechnology
- ISIN
- JP3423580004
- Market cap
- 6B
- P/E ratio
- 89.33
- Analyst target
- 880
- Dividend yield
- 1.5%
- Beta
- -0.09
About
About CellSource Co., Ltd
CellSource Co., Ltd. engages in the regenerative medicine-related businesses in Japan. The company provides processing services to extract adipose-derived stem cells from patients' adipose tissues, and to prepare platelet-rich plasma from patients' blood; and offers support services for medical facilities providing regenerative medicine therapy. It is also involved in the sale of human stem cell-derived cosmetic ingredients; and Signalift series of anti-aging products, including a serum. The company was incorporated in 2015 and is headquartered in Shibuya, Japan.
Visit company websiteCommunity
Investor discussion
0 comments
Sign in to join the 4880.TSE discussion.
No comments yet
Start a focused discussion about 4880.TSE.